[Muscle weakness as first manifestation of panhypopituitarism secondary to empty sella syndrome].
Paz Flores
C
C
Rosales Carballa
J
J
Blanco Loberías
J
J
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004652:Empty Sella Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D007018:Hypopituitarism / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D008279:Magnetic Resonance Imaging; D018908:Muscle Weakness / Q000209:etiology*; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D013974:Thyroxine; D006854:Hydrocortisone